SOME MARKERS OF HBeAg, ANTI-HBe, HBcrAg, HBV-DNA IN UNTREATED CHRONIC HEPATITIS B PATIENTS AND RELATED FACTORS

Trang Trần Thị Diễm, Dung Trần Ngọc, Loan Dương Thị, Kha Trương Đan, Mai Huỳnh Thị Huỳnh, Vy Đoàn Phù Tường, Trắng Trần Hoàng, Trí Võ Thành

Main Article Content

Abstract

Background: Several serological markers have been evaluated for their association with disease severity and have significance in the diagnosis and monitoring of treatment in patients with chronic hepatitis B. Objective: To investigate certain serological markers HBeAg, anti-HBe, HBcrAg levels, HBV-DNA and related factors in untreated patients with chronic hepatitis B at S.I.S Can Tho International General Hospital from 2023 to 2025. Materials and Methods: This is a cross-sectional descriptive study with analytical components conducted on 100 patients with confirmed diagnoses of untreated chronic hepatitis B who visited the Gastroenterology Clinic at S.I.S Can Tho International General Hospital from July 2024 to February 2025. The patients underwent qualitative testing for HBeAg and anti-HBe, quantitative measurement of HBcrAg, and assessment of HBV-DNA viral load. Data were collected and analyzed using SPSS version 25.0. Results: The proportion of patients who HBeAg(+) was 26,0%, anti-HBe(+) was 74,0%, HBcrAg(+) was 80,0%, and HBV-DNA(+) was 97,0%. The mean age of the study population was 48,44±13,1 years, Males were slightly more predominant (51,0%) compared to females (49,0%), and the majority of participants resided in rural areas (76,0%). Among patients with HBeAg(+), the mean ALT activity was 83,5±115,7 U/L, AST was 62,9±63,5 U/L, and the mean concentrations of HBcrAg and HBV-DNA were 7,45±1,45 logU/mL and 5,89±2,47 log₁₀ IU/mL. Conclusion: The proportion of chronic hepatitis B patients with HBeAg(+) was 26,0%, while those with HBeAg(-) made up 74,0%. Patients in the HBeAg(+) group were younger than those in the HBeAg(-) group, with an OR=3,37 (p=0,01). No statistically significant association were found in HBeAg status regarding gender, residence, AST and ALT levels. The mean concentrations of HBcrAg and HBV-DNA were significantly higher in the HBeAg(+) group than in the HBeAg(-) group (p<0,001).

Article Details

References

1. Cui F, Blach S, Manzengo Mingiedi C, Gonzalez M. A, Sabry Alaama A, Mozalevskis A, et al (2023), "Global reporting of progress towards elimination of hepatitis B and hepatitis C", Lancet Gastroenterol Hepatol, 8(4), pp.332-342.
2. Lê Đình Vĩnh Phúc (2020), “Nghiên cứu một số đặc điểm kháng nguyên liên quan đến lõi vi rút viêm gan B tại trung tâm MEDIC thành phố Hồ Chí Minh”, Tạp chí Truyền nhiễm Việt Nam, 4(32), tr.80-85.
3. Nguyễn Thị Cẩm Hồng, Đỗ Hoàng Long, Lê Thị Hoàng Mỹ, Trịnh Thị Hồng Của & Phan Hoàng Đạt (2022), “Nghiên cứu các dấu ấn huyết thanh nhiễm HBV, mối tương quan giữa nồng độ HBsAg và tải lượng vi rút ở bệnh nhân viêm gan B mạn chưa điều trị tại Bệnh viện trường Đại học Y Dược Cần Thơ năm 2021-2022, Tạp chí Y Dược học Cần Thơ, 51, 205-212.
4. Lê Văn Nam (2021), “Nghiên cứu mối tương quan giữa tải lượng HBV DNA và hoạt độ enzym ALT ở bệnh nhân viêm gan vi rút B mạn tính”, Tạp chí Y học Việt Nam, 2(500), tr.95-99.
5. Liu D, Xu T, Shi B, Lu W, et al (2020). “Clinical relevance of the in situ assay for HBV DNA: a cross-sectional study in patients with chronic hepatitis B”, J Clin Pathol, 73(12, pp.813-818.
6. Yang N. Feng T, Zhou T, Li Z, et al (2018), “Relationship betwween serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients”, J Med Virol, 90(7), pp.1240-1245.
7. Mai Thị Bích Chi (2022), “Khảo sát nồng độ HBcrAg huyết thanh ở bệnh nhân viêm gan B mạn tại bệnh viện đại học y dược TPHCM”, Trường Đại học Y Dược TP.HCM, tr.350-381.